The share of the UK's scientific publications in the world’s top 10% cited for Immunology and Microbiology shows a gradual increase from 2024 to 2028, with values projected from 15.18% to 15.21%. This marks a stable trend, given that in 2023, the share was slightly below 15.18%. This steady growth reflects a consistent performance in the UK's research output in these fields. The year-on-year variations are minimal, with less than a 0.01% increase each year, suggesting a maturity phase in citation impact rather than a rapid growth period.
Future trends to watch include the impact of emerging technologies like AI and machine learning on research productivity, potential changes in funding and collaboration post-Brexit, and evolving global health challenges that may shift focus and increase the citation impacts on specific research within these fields.
